On this episode of The Tudor Dixon Podcast, Tudor Dixon welcomes back Dr. Josef Witt-Doerring for a candid conversation on the growing push to legalize psychedelics and cannabis—and the serious mental health questions that come with it. They break down the differences between psychedelics and SSRIs, why traditional mental health treatment may be failing so many Americans, and what new therapies could mean for the future of treatment.

The conversation also explores the risks of high-potency cannabis, cannabis-induced psychosis, the mental health side effects linked to GLP-1 drugs like Ozempic, and the rise of AI-driven telehealth prescribing. If you’ve ever wondered whether America is moving too fast on drug legalization—or what these substances really do to the brain—this episode is a must-listen.